Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
5.980 / 17.026
#47833

Re: Farmas USA

Flu Vaccine vs NVAX
A GSK spokesperson said in an emailed statement Wednesday that the company is "fully committed to working with regulators to ensure we adhere to the requirements of all Good Manufacturing Practices." It also said that the agency had given it a "compliant rating" and that it was "making progress on their concerns."

But meeting Health Canada's concerns are only part of the difficulty the facility faces because Health Canada went in for a look only after problems were initially identified in a warning letter the FDA sent the facility in June.

FDA inspectors questioned the quality of the new FluLaval vaccine and its intermediates. It said that of 20 lots manufactured this year, 21% had to be rejected because of bacterial growth and problems with "endotoxin excursions." It also said that in April 2013, contamination was the cause of 80% of rejected eggs. In August 2013, the agency approved FluLaval Quadrivalent, which protects against four flu strains. The fact that GSK appeared to be struggling led the agency to ask for a meeting with senior management, "given the potential contributions of FluLaval to the public health."

GSK is slated to provide between 28 million and 33 million doses of four-strain and three-strain flu shots to the U.S. market for the 2014-2015 season. It said last week that it had begun shipping the first doses of Fluarix Quadrivalent, which make up part of that commitment. That vaccine is manufactured at a plant in Dresden, Germany.

http://www.fiercepharmamanufacturing.com/story/out-new-and-old-after-gsk-trips-vaccine-plant/2014-07-23?utm_medium=nl&utm_source=internal

#47835

Re: Farmas USA

Yo, por si acaso, ayer compré algunas acciones de GSK, que están en mínimos después de los resultados semestrales.

También estoy en NVAX, claro.

#47836

Re: Farmas USA

Gracias Framus.
El gráfico que has bajado da miedo, parece que hace los mismos patrones. En fin entiendo que ahora con la mejora de la empresa, el gráfico cambie.

#47836

Re: Farmas USA

Gracias Framus.
El gráfico que has bajado da miedo, parece que hace los mismos patrones. En fin entiendo que ahora con la mejora de la empresa, el gráfico cambie.

#47840

Re: Farmas USA

Abordes, me ha dado por mirar el grafico a ver como andaba GSK

El Mensual es tremendo superando en 2013 la gran bajista que tenia desde 1998. 

 

 

La salida de ayer , post-earnings, segun dice Konkorde fue salida retail . 

y creo que ha venido muy bien para dar un respiro a indicadores.

La alcista que lleva desde el 2009 es buenisima. 

 

Haciendo zoom en Grafica SEMANAL de los ultimos 5-6 años ...

 

fijate como rompe la bajista, con un gap que luego posteriormente es tapado para terminar la sombra inferior justo rebotando en dicha bajista. Es genial, al milimetro.

La MM100 semanal esta en estos niveles, en 50, no estaria mal que el cierre de esta semana estuviera por encima.

GSK